ログイン

MTLBE

MTLBE
100問 • 1年前
  • Yves Laure Pimentel
  • 通報

    問題一覧

  • 1

    Concentrated formalin is * 0/1 A. 10% B. 100% C. 37% D. 5%

    C. 37%

  • 2

    Staining result in the routine hematoxylin and eosin method: * 1/1 A. Nuclei pink, cytoplasm blue to blue-black B. Nuclei and cytoplasm pink C. Nuclei blue to blue-black, cytoplasm pink D. Nuclei and cytoplasm blue-black

    C. Nuclei blue to blue-black, cytoplasm pink

  • 3

    A paraffin wax substitute recommended for bones and brain specimen is * 0/1 A. Paraplast B. Bioloid C. Esterwax D. Carbowax

    A. Paraplast

  • 4

    The required fixative volume to achieve satisfactory fixation is * 1/1 A. 50-100 x the volume of the specimen B. 5-10 x the volume of the specimen C. 20 x the volume of the specimen D. 150 x the volume of the specimen

    C. 20 x the volume of the specimen

  • 5

    The fastest chemical solution in decalcifying tissues is: * 1/1 A. Trichloroacetic acid B. Formic acid C. Nitric acid D. Versene

    C. Nitric acid

  • 6

    The cryostat is an apparatus used in fresh tissue microtomy. It consists of a microtome, kept inside a cold chamber which has been maintained at a temperature of: * 1/1 A. 20ᵒC B. -20ᵒC C. 4ᵒC D. -4ᵒC

    B. -20ᵒC

  • 7

    Microtome suitable for Fatty Tissues * 1/1 A. Rotary B. Rocking C. Cold Microtome D. Sliding

    C. Cold Microtome

  • 8

    Removal of clearing agent as well as filling up tissue cavities and spaces may be accomplished using which of the following agents * 1/1 A. Amyl acetate B. methyl salicylate C. Paraffin wax D. Terpineol

    C. Paraffin wax

  • 9

    Most commonly antibody label in immunohistochemistry * 0/1 A. colloidal gold B. fluorescein isothiocyanate C. radiolabel D. horseradish peroxidase

    D. horseradish peroxidase

  • 10

    To ensure adequate fixation, slightly hypertonic solution must be used. This is about 400-450 mOsm * 0/1 A. Only the 1st statement is correct B. Only the 2nd statement is correct C. Both statements are correct D. Both statements are incorrect

    C. Both statements are correct

  • 11

    The chromogen used in partnership with HRP is * 0/1 A. Para dimethylaminobenzaldehyde B. P-dimethyl-l-naphthylamine C. Diaminobenzidine D. none of these

    C. Diaminobenzidine

  • 12

    Cellular adaptation Mechanism that involves transformation of adult cell into another adult cell type is * 0/1 A. Metaplasia B. neoplasia C. Dysplasia D. Anaplasia

    A. Metaplasia

  • 13

    Which of the following is NOT a fixing agent for EM? * 1/1 A. Paraformaldehyde B. Glutaraldehyde C. uranyl acetate D. osmium tetroxide

    C. uranyl acetate

  • 14

    Which of the following statement is TRUE regarding dehydration? * 0/1 A. The specimen is subjected to ascending concentrations of alcohol B. The specimen is subjected to several changes of alcohol with the same concentrations C. The specimen is subjected to descending concentrations of alcohol D. The specimen is subjected to both ascending and descending concentration of alcohol

    A. The specimen is subjected to ascending concentrations of alcohol

  • 15

    Secondary change in somatic death important in establishing time of death * 0/1 A. putrefaction B. algor mortis C. rigor mortis D. livor mortis

    B. algor mortis

  • 16

    Which of the following is an example of pathologic hypertrophy? * 0/1 A. Removing part of the liver /kidney B. Increase in breast and uterus size during pregnancy C. Myocardium in hypertension or aortic valve disease D. Increase in skeletal muscles following exercise

    C. Myocardium in hypertension or aortic valve disease

  • 17

    Abnormality in cell growth characterized by non-appearance of organ * 1/1 A. Aplasia B. hypoplasia C. atresia D. agenesia

    D. agenesia

  • 18

    All of the following are slow acting clearing agents hence not suited for urgent biopsies except * 1/1 A. Benzene B. clove oil C. cedarwood oil D. methyl benzoate

    A. Benzene

  • 19

    This technique entails the use of specific dyes, which differentiate substances by staining them with a color that is different from that of the stain itself: * 1/1 A. Orthochromatic staining B. Metachromatic staining C. Counterstaining D. Vital staining

    B. Metachromatic staining

  • 20

    To avoid distortion of the image, the refractive index of the mountant should be near as possible to that of the glass which is: * 1/1 A. 1. 581 B. 1.185 C.1.518 D. 1.524

    C.1.518

  • 21

    The cellular infiltrate in acute inflammation * 1/1 A. neutrophils B. plasma cells C. macrophage D. lymphocytes

    A. neutrophils

  • 22

    Fixation of tissues for EM is carried out at * 0/1 A. 22-25 degC B. 40 degC C. 4 degC D. 37 deg

    C. 4 degC

  • 23

    Which of the following are Picric acid containing fixatives? 1.Brasil’s 2. Hollande’s 3. Bouin’s 4. Regaud’s * 0/1 A. 1 and 3 B. 2 and 4 C. 1,2 and 3 D. 1,2,3 and 4

    C. 1,2 and 3

  • 24

    Clearing agent that becomes milky because of incomplete dehydration is * 1/1 A. Chloroform B. xylene C. benzene D. cedarwood oil

    B. xylene

  • 25

    Thickness of paraffin sections for routine histologic procedures: * 1/1 A.10-15 µ B. 4-6 µ C.0.5 µ D. 5-10 µ

    B. 4-6 µ

  • 26

    Process whereby the clearing agent is completely removed from the tissue and replaced by a medium that will completely fill all the tissue cavities: * 0/1 A. Embedding B. Infiltration C. Blocking D. Casting

    B. Infiltration

  • 27

    With this staining technique, the tissue is first overstained, and the excess stain is removed or decolorized from unwanted part of the tissue: * 0/1 A. Progressive staining B. Direct staining C. Regressive staining D. Indirect staining

    C. Regressive staining

  • 28

    True of Necrosis except * 1/1 A. Characterized by cell shrinkage B. There is leakage of cellular contents C. Possible inflammation in adjacent tissues D. Always a pathologic process

    A. Characterized by cell shrinkage

  • 29

    The process of decalcification is best performed: * 1/1 A. Before fixation B. After fixation C. After impregnation D. None of these

    B. After fixation

  • 30

    microscopic changes in reversible injury 1. karyorrhexis 2. fatty change 3. pyknosis 4. cellular swelling * 0/1 A. 1 and 3 B. 1 and 4 C. 2 and 4 D. 2 and 3

    C. 2 and 4

  • 31

    Autopsy technique that involves “en bloc” removal or organs * 1/1 A. R. virchow B. A. Ghon C. C. Rokitansky D. M. letulle

    B. A. Ghon

  • 32

    Black mercury deposits following fixation can be removed by using which washing reagent? * 1/1 A. 50-70% alcohol B. alcoholic iodine C. tap water D. lithium carbonate

    B. alcoholic iodine

  • 33

    Clearing agent recommended for CNS and Cytologic studies * 0/1 A. Chloroform B. Cedarwood oil C. Xylene D. Aniline oil

    B. Cedarwood oil

  • 34

    What is the most commonly used tissue fixative in routine Histopath? * 1/1 A. 95% ethanol B. 95% ethanol and ether C. 10% BNF D. Osmium tetroxide

    C. 10% BNF

  • 35

    Ciliated columnar cells lining the bronchi transforming into squamous epithelium due to excessive cigarette smoking is an example of * 1/1 A. Metaplasia B. Neoplasia C. Dysplasia D. Anaplasia E. none of these

    A. Metaplasia

  • 36

    Which of the following fixatives are classified as Mercuric Chloride Fixatives? * 1/1 A. Zenker’s, Hollande’s, B5 B. Helly’s, Brasil’s, Regauds C. Heidenhain’s Susa, B5, Zenker-formol D. orth’s, Helly’s, B5

    C. Heidenhain’s Susa, B5, Zenker-formol

  • 37

    The last container through which tissue pass through in an automatic tissue processor contains: * 0/1 A. Paraffin B. Formalin C. Xylol D. Alcohol

    A. Paraffin

  • 38

    Which of the following is added to prevent growth of molds in Mayer’s egg albumin * 1/1 A. Glycerine B. Phenol C. Thymol crystals D. sugar

    C. Thymol crystals

  • 39

    Which of the following fixatives is recommended for tumor skin biopsies * 1/1 A. Zenker’s fluid B. Heidenhain’s Susa C. Carnoy’s D. Acetone

    B. Heidenhain’s Susa

  • 40

    All of the following are metachromatic stains, EXCEPT: * 1/1 A. Thionine B. Toluidine blue C. Safranin D. Eosin

    D. Eosin

  • 41

    Liquefactive necrosis is associated with which of the following organs: * 1/1 a. Brain b. Heart c. Pancreas d. Spleen

    a. Brain

  • 42

    During dehydration, the amount in each stage should not be less than ____ times the volume of the tissue. * 1/1 a. 5 b. 10 c. 15 d. 20

    b. 10

  • 43

    All of these are the advantages of Flemming’s solution fixative for nuclear preservation, except: * 0/1 a. Less volume required for fixation b. Permanently fixes fat c. Excellent fixative for chromosomes d. Good penetrating agent

    d. Good penetrating agent

  • 44

    Resealing of the block is recommended: * 0/1 a. To prevent drying of tissues b. To prevent crumbling of tissue blocks c. To prevent deterioration of tissue within the block d. To protect the block from direct heat

    a. To prevent drying of tissues

  • 45

    All of the following statements are true about paraformaldehyde, except: * 0/1 a. Causes turbidity in formalin b. Forms from the breakdown of formalin into monomeric segments c. Can be removed by filtration d. Prevented from forming due to addition of 10-16% methanol

    b. Forms from the breakdown of formalin into monomeric segments

  • 46

    The basic FNAB technique uses what needle and syringe measurements? * 0/1 a. 25-gauge needle and 10-mL syringe b. 25-gauge needle and 5-mL syringe c. 23-gauge needle and 10-mL syringe d. 23-gauge needle and 5-ml syringe

    a. 25-gauge needle and 10-mL syringe

  • 47

    It is the process of removing mercuric deposits from fixed tissues by immersing them in alcoholic iodine solution prior to staining. * 1/1 a. Post-chromatization b. De-zenkerization c. Washing out d. Post-fixation immersion

    b. De-zenkerization

  • 48

    Mercuric chloride fixatives: 1. Zenker’s fluid 2. Heidenhain Susa solution 3. Helly’s solution 4. B5 * 0/1 a. 1, 2, 3, 4 b. 1, 2, 3 c. 1, 2, 4 d. 1, 3, 4

    a. 1, 2, 3, 4

  • 49

    In the preparation of a working solution for both Ehrlich’s and Harris hematoxylin, hematoxylin is initially dissolved in: * 0/1 a. Distilled water b. Glacial acetic acid c. Ethyl alcohol d. Deionized water

    c. Ethyl alcohol

  • 50

    Mounting solution is placed on the slide after it has passed * 1/1 a. Alcohol b. Xylol c. Hematoxylin d. Eosin

    b. Xylol

  • 51

    Brown-black granules present in the specimen due to acid formaldehyde hematin can be removed by all of the following, except: * 0/1 a. Kardasewitsch method b. Lillie’s method c. Alcoholic potassium hydroxide d. Glacial acetic acid

    d. Glacial acetic acid

  • 52

    During double embedding, a tissue specimen is initially infiltrated using _______ then embedded using ________. * 1/1 a. Celloidin, paraffin b. Paraffin, celloidin c. Celloidin, gelatin d. Paraffin, gelatin

    a. Celloidin, paraffin

  • 53

    One of these is not a special stain for fat * 1/1 a. Oil red O b. Congo red c. Sudan IV d. Scharlach R

    b. Congo red

  • 54

    It is an instrument equipped with a warm plate to manage the impregnated specimen, and a cold plate for rapid solidification of the block. * 1/1 a. Autotechnicon b. Elliot Bench-Type processor c. Vacuum embedding d. Tissue Tek

    d. Tissue Tek

  • 55

    Fixation is enhanced by: * 0/1 a. Presence of fat and mucus b. Fixing larger tissues c. Cold temperature d. Agitation

    d. Agitation

  • 56

    The following are agents for blueing, except: * 0/1 a. Lithium carbonate b. Alcohol ammonia c. Scott’s tap water d. Distilled water

    d. Distilled water

  • 57

    Widely used adhesive in IHC: * 0/1 a. Poly-L-Lysine b. APES c. XAM d. DPX

    a. Poly-L-Lysine

  • 58

    Secondary fixation can be done: 1. Before dehydration 2. Before staining 3. Depends on circumstances * 0/1 a. 1, 2, 3 b. 1 and 2 c. 1 only d. 2 only

    b. 1 and 2

  • 59

    Aplastic anemia and bone marrow disease is attributed mostly to: * 0/1 a. Xylene b. Toluene c. Chloroform d. Benzene

    d. Benzene

  • 60

    All of the following are considered resinous mounting media, except: * 1/1 a. Apathy b. Canada Balsam c. Clarite d. XAM

    a. Apathy

  • 61

    Mounting medium 1. APES 2. DPX 3. Poly-L-Lysine 4. XAM * 0/1 a. 1, 2, 3, 4 b. 1, 2, 4 c. 1 and 3 d. 2 and 4

    d. 2 and 4

  • 62

    Cytologic preparation of vulvar scrape is useful in: * 0/1 a. Patients with hysterectomy b. Hormonal evaluation c. Localization of vaginal adenosis d. Detection of herpetic lesions or carcinomas

    d. Detection of herpetic lesions or carcinomas

  • 63

    All of the following are staining method used to demonstrate CNS elements, except: * 0/1 a. Bielschowsky Technique b. Bodian’s Stain c. Cresyl fast violet d. Modified Fouchet’s technique

    d. Modified Fouchet’s technique

  • 64

    The first and most important procedure in the preparation for microscopic examination is the choice of: * 1/1 a. Fixative b. Dehydrating agent c. Clearing agent d. Staining technique

    a. Fixative

  • 65

    The fluorescent stain for amyloid is: * 0/1 a. Congo red b. Argentaffin c. Thioflavin T d. Toluidine blue

    c. Thioflavin T

  • 66

    To demonstrate antibodies and enzymes in tissues, the following procedure is used: * 1/1 a. Special staining technique b. Electron microscopy c. Frozen section examination d. Routine H&E

    c. Frozen section examination

  • 67

    Xylene turns milky as soon as tissue is placed in it. What could be the possible cause? * 1/1 a. Incomplete dehydration b. Incomplete fixation c. Prolonged dehydration d. Prolonged fixation

    a. Incomplete dehydration

  • 68

    A special method of smear preparation whereby the surface of a freshly cut piece of tissue is brought into contact and pressed onto the surface of a clean glass slide, allowing cells to be transferred directly to the slide for examination: * 0/1 a. Impression smear b. Pull apart c. Streaking d. Crushing

    a. Impression smear

  • 69

    All of the following tests are used for the detection of the completion of decalcification, except: * 1/1 a. Physical or mechanical b. Absorption test c. Chemical test d. X-ray or radiologic test

    b. Absorption test

  • 70

    Slices of organs taken at autopsy (except lung) should not be * 1/1 a. More than 10 mm thick b. Less than 5 mm thick c. More than 5 mm thick d. Less than 10 mm thick

    c. More than 5 mm thick

  • 71

    In autopsy, microbiological culture to demonstrate infection of the central nervous system can use which of the following specimen: * 0/1 a. Fresh serum b. Fresh cerebrospinal fluid c. Whole blood d. Fresh brain tissue

    d. Fresh brain tissue

  • 72

    This fixative is used to demonstrate early degenerative processes and tissue necrosis; can be used for fixation of Rickettsia and other microorganisms * 0/1 a. Regaud’s Fluid b. Moller’s Fluid c. Chromic Acid d. Orth’s Fluid

    d. Orth’s Fluid

  • 73

    Non-chemical technique/s useful in preserving neurochemical substances in brain, such as acetylcholine. * 0/1 a. Microwave Technique b. Vacuum Technique c. Heating Technique d. All of the above

    d. All of the above

  • 74

    What percentage of formalin is distributed commercially? * 0/1 a. 10% b. 40% c. 100% d. 4%

    b. 40%

  • 75

    Airholes found in tissue during trimming is: * 1/1 a. Drying out of tissue before actual fixation b. Incomplete fixation c. Incomplete impregnation d. Prolonged clearing

    c. Incomplete impregnation

  • 76

    The most popular and commonly used embedding medium is * 1/1 a. Carbowax b. Paraplast c. Paraffin d. Celloidin

    c. Paraffin

  • 77

    77. Picric acid fixatives, except: 1. Helly’s 2. Heidehain Susa solution 3. Orth’s fluid 4. B5 * 0/1 a. 1, 2, 3, 4 b. 1, 2, 3 c. 4 only d. None

    a. 1, 2, 3, 4

  • 78

    What substance is used to test water content in alcohol used for dehydration? * 1/1 a. Anhydrous copper sulfate b. Anyhydrous copper oxide c. Anhydrous copper silicide d. Anhydrous copper sulfide

    a. Anhydrous copper sulfate

  • 79

    The turnover of results for frozen sections should be within: * 1/1 a. 24 hours b. 5-15 minutes c. 1 week d. 3 days

    b. 5-15 minutes

  • 80

    Use of EDTA as a decalcifying agent inactivates alkaline phosphatase activity. What reagent is added to restore enzymatic activity? * 1/1 a. Magnesium chloride b. Acid lithium carbonate c. Copper sulfate d. Lead bromide

    a. Magnesium chloride

  • 81

    As to service capability, a primary laboratory caters: I. Routine Clinical Chemistry II. Routine Hematology and Urinalysis III. Bleeding time IV. Quantitative platelet determination * 0/1 A. I, II, III B. I, II, IV C. I, III, IV D. All of these

    C. I, III, IV

  • 82

    Validity of COA of a screening Drug Test Laboratory: * 1/1 A. 6 months B. 1 year C. 2 year D. Indefinite

    B. 1 year

  • 83

    The current PRC Chairperson is: * 1/1 A. Charito Zamora B. Jose Cueto C. Erwin Enad D. Luella Vertucio

    A. Charito Zamora

  • 84

    Fist clinical laboratory in the Philippines: * 1/1 A. San Lazaro Hospital B. Manila Public Health Laboratory C. Research Institute for Tropical Medicine D. National Reference Laboratory

    B. Manila Public Health Laboratory

  • 85

    A sample of persons from a population is enrolled and their exposures and health outcomes are measured simultaneously. * 1/1 A. Cross-sectional study B. Cohort study C. Case control studies D. Causation Study

    A. Cross-sectional study

  • 86

    Refers to a list of minimum legally core parameters for drinking water analysis such as total dissolved solids, thermotolerant coliform and chemicals: * 0/1 A. Water Analysis Parameters B. Control parameters C. Bacteriological Parameters D. Mandatory Parameters

    D. Mandatory Parameters

  • 87

    National Reference Laboratory for Environmental and Occupational Health; Toxicology and Micronutrient Assay: * 0/1 A. RITM B. San Lazaro Hospital C. East Avenue Medical Center D. Lung Center of the Philippines

    C. East Avenue Medical Center

  • 88

    A deceased individual and includes a stillborn infant or fetus: * 1/1 A. Testator B. Donor C. Decedent D. Part

    C. Decedent

  • 89

    RESPECT the decisions (self-determination) of adult who have decision-making capacity. Moral rules or obligations: ▪ Tell the truth ▪ Respect the privacy ▪ Protect confidential information ▪ Obtain consent for interventions with patients * 1/1 A. Autonomy B. Beneficence C. Non-maleficence D. Justice

    A. Autonomy

  • 90

    What is the most important role of the manager in charge? * 0/1 A. Independent decision making B. Communication C. Informal discussions D. None of the above

    B. Communication

  • 91

    ISO Standard and certification formulated for clinical laboratories: * 0/1 A. ISO 15179 B. ISO 15197 C. ISO 15189 D. ISO 15198

    D. ISO 15198

  • 92

    Consists of educational arrangements such as curricular qualifications and teaching-learning requirements that leads to diplomas and qualifications: * 0/1 A. Formal learning B. Non-formal learning C. Informal learning D. Professional work experiences

    A. Formal learning

  • 93

    All of the following are Quality Management errors during the post examination phase, except: * 1/1 A. Failure to call critical values B. Inability to identify interfering substance C. Misinterpretation of QC data D. Poor handwriting

    C. Misinterpretation of QC data

  • 94

    When fire is first discovered: * 1/1 A. Alarm - Rescue - Contain – Extinguish /Evacuate B. Rescue - Alarm - Contain – Extinguish/Evacuate C. Rescue - Alarm – Contact personnel – Extinguish/Evacuate D. Rescue - Alarm – Extinguish/Evacuate - Contact personnel

    B. Rescue - Alarm - Contain – Extinguish/Evacuate

  • 95

    An agency attached to DOH that is primarily tasked to ensure the implementation of the country’s response to the HIV and AIDS situation: * 1/1 A. Philippine Red Cross B. Philippine National AIDS Council (PNAC) C. Philippine Movement AIDS Council D. None of these

    B. Philippine National AIDS Council (PNAC)

  • 96

    Any members of the Board may be removed by the President of the Philippines for: I. Neglect of Duty II. Incompetency III. Non-compliance IV. Malpractice V. Dishonorable conduct VI. Tardiness * 1/1 A. I, II, III, IV B. I, II, III, V C. I, III, IV, V D. I, II, IV, V

    D. I, II, IV, V

  • 97

    When washing hands, rinse hands in a _______ position to prevent recontamination of hands and wrists: * 1/1 A. Upward B. Downward C. Facing the faucet D. None of these

    B. Downward

  • 98

    Every applicant who has satisfactorily passed the required examination for medical technologist shall be issued a certificate of registration (COR) as such: Provided, that no such certificate shall be issued to any successful applicant who has not attained the age of _____. * 1/1 A. 20 y/o B. 21 y/o C. 22 y/o D. 23 y/o

    B. 21 y/o

  • 99

    Organ Donation Act of 1991: * 1/1 A. RA 1517 B. RA 4688 C. RA 7170 D. RA 9165

    C. RA 7170

  • 100

    R.A 11223: * 0/1 A. Universal Health Care Act B. Human Trafficking Act of 1995 C. Science and Technology Act D. Universal Water Care Act

    D. Universal Water Care Act

  • HTMLBE

    HTMLBE

    Yves Laure Pimentel · 64問 · 2年前

    HTMLBE

    HTMLBE

    64問 • 2年前
    Yves Laure Pimentel

    PARASITOLOGY

    PARASITOLOGY

    Yves Laure Pimentel · 111問 · 2年前

    PARASITOLOGY

    PARASITOLOGY

    111問 • 2年前
    Yves Laure Pimentel

    other names parasitology

    other names parasitology

    Yves Laure Pimentel · 70問 · 2年前

    other names parasitology

    other names parasitology

    70問 • 2年前
    Yves Laure Pimentel

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    Yves Laure Pimentel · 61問 · 2年前

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    61問 • 2年前
    Yves Laure Pimentel

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    Yves Laure Pimentel · 69問 · 2年前

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    69問 • 2年前
    Yves Laure Pimentel

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    Yves Laure Pimentel · 100問 · 2年前

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    100問 • 2年前
    Yves Laure Pimentel

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    Yves Laure Pimentel · 41問 · 2年前

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    41問 • 2年前
    Yves Laure Pimentel

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    Yves Laure Pimentel · 87問 · 2年前

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    87問 • 2年前
    Yves Laure Pimentel

    CSF 1

    CSF 1

    Yves Laure Pimentel · 100問 · 2年前

    CSF 1

    CSF 1

    100問 • 2年前
    Yves Laure Pimentel

    CSF 2

    CSF 2

    Yves Laure Pimentel · 82問 · 2年前

    CSF 2

    CSF 2

    82問 • 2年前
    Yves Laure Pimentel

    SEMEN 1

    SEMEN 1

    Yves Laure Pimentel · 100問 · 2年前

    SEMEN 1

    SEMEN 1

    100問 • 2年前
    Yves Laure Pimentel

    SEMEN 2

    SEMEN 2

    Yves Laure Pimentel · 7問 · 2年前

    SEMEN 2

    SEMEN 2

    7問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    Yves Laure Pimentel · 100問 · 2年前

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    100問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    Yves Laure Pimentel · 6問 · 2年前

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    6問 • 2年前
    Yves Laure Pimentel

    SEROUS FLUID

    SEROUS FLUID

    Yves Laure Pimentel · 25問 · 2年前

    SEROUS FLUID

    SEROUS FLUID

    25問 • 2年前
    Yves Laure Pimentel

    PLEURAL FLUID

    PLEURAL FLUID

    Yves Laure Pimentel · 44問 · 2年前

    PLEURAL FLUID

    PLEURAL FLUID

    44問 • 2年前
    Yves Laure Pimentel

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    Yves Laure Pimentel · 18問 · 2年前

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    18問 • 2年前
    Yves Laure Pimentel

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    Yves Laure Pimentel · 30問 · 2年前

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    30問 • 2年前
    Yves Laure Pimentel

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    Yves Laure Pimentel · 92問 · 2年前

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    92問 • 2年前
    Yves Laure Pimentel

    FECALYSIS

    FECALYSIS

    Yves Laure Pimentel · 80問 · 2年前

    FECALYSIS

    FECALYSIS

    80問 • 2年前
    Yves Laure Pimentel

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    Yves Laure Pimentel · 89問 · 2年前

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    89問 • 2年前
    Yves Laure Pimentel

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    Yves Laure Pimentel · 86問 · 2年前

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    86問 • 2年前
    Yves Laure Pimentel

    MTLBE..

    MTLBE..

    Yves Laure Pimentel · 35問 · 2年前

    MTLBE..

    MTLBE..

    35問 • 2年前
    Yves Laure Pimentel

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    Yves Laure Pimentel · 19問 · 1年前

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    19問 • 1年前
    Yves Laure Pimentel

    CC-OSMOMETRY

    CC-OSMOMETRY

    Yves Laure Pimentel · 14問 · 1年前

    CC-OSMOMETRY

    CC-OSMOMETRY

    14問 • 1年前
    Yves Laure Pimentel

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    Yves Laure Pimentel · 43問 · 1年前

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    43問 • 1年前
    Yves Laure Pimentel

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    Yves Laure Pimentel · 49問 · 2年前

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    49問 • 2年前
    Yves Laure Pimentel

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    Yves Laure Pimentel · 97問 · 2年前

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    97問 • 2年前
    Yves Laure Pimentel

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    Yves Laure Pimentel · 57問 · 2年前

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    57問 • 2年前
    Yves Laure Pimentel

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    Yves Laure Pimentel · 63問 · 2年前

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    63問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 37問 · 2年前

    PROTEINS

    PROTEINS

    37問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    Yves Laure Pimentel · 91問 · 2年前

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    91問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    Yves Laure Pimentel · 98問 · 2年前

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    98問 • 2年前
    Yves Laure Pimentel

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    Yves Laure Pimentel · 61問 · 2年前

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    61問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 1

    Liver Function Test 1

    Yves Laure Pimentel · 100問 · 2年前

    Liver Function Test 1

    Liver Function Test 1

    100問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 2

    Liver Function Test 2

    Yves Laure Pimentel · 96問 · 2年前

    Liver Function Test 2

    Liver Function Test 2

    96問 • 2年前
    Yves Laure Pimentel

    TUMOR MARKERS

    TUMOR MARKERS

    Yves Laure Pimentel · 33問 · 2年前

    TUMOR MARKERS

    TUMOR MARKERS

    33問 • 2年前
    Yves Laure Pimentel

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    Yves Laure Pimentel · 41問 · 2年前

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    41問 • 2年前
    Yves Laure Pimentel

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    Yves Laure Pimentel · 17問 · 2年前

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    17問 • 2年前
    Yves Laure Pimentel

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    Yves Laure Pimentel · 14問 · 2年前

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    14問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 71問 · 2年前

    PROTEINS

    PROTEINS

    71問 • 2年前
    Yves Laure Pimentel

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    Yves Laure Pimentel · 7問 · 2年前

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    7問 • 2年前
    Yves Laure Pimentel

    ELECTROLYTES

    ELECTROLYTES

    Yves Laure Pimentel · 10問 · 2年前

    ELECTROLYTES

    ELECTROLYTES

    10問 • 2年前
    Yves Laure Pimentel

    DRUGS

    DRUGS

    Yves Laure Pimentel · 27問 · 2年前

    DRUGS

    DRUGS

    27問 • 2年前
    Yves Laure Pimentel

    TOXIC AGENTS:

    TOXIC AGENTS:

    Yves Laure Pimentel · 12問 · 2年前

    TOXIC AGENTS:

    TOXIC AGENTS:

    12問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    Yves Laure Pimentel · 100問 · 2年前

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    100問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    Yves Laure Pimentel · 29問 · 2年前

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    29問 • 2年前
    Yves Laure Pimentel

    hema diseases

    hema diseases

    Yves Laure Pimentel · 25問 · 2年前

    hema diseases

    hema diseases

    25問 • 2年前
    Yves Laure Pimentel

    AML

    AML

    Yves Laure Pimentel · 43問 · 2年前

    AML

    AML

    43問 • 2年前
    Yves Laure Pimentel

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    Yves Laure Pimentel · 71問 · 2年前

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    71問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    Yves Laure Pimentel · 31問 · 2年前

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    31問 • 2年前
    Yves Laure Pimentel

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    Yves Laure Pimentel · 34問 · 2年前

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    34問 • 2年前
    Yves Laure Pimentel

    PLATELET DISORDERS

    PLATELET DISORDERS

    Yves Laure Pimentel · 37問 · 2年前

    PLATELET DISORDERS

    PLATELET DISORDERS

    37問 • 2年前
    Yves Laure Pimentel

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    Yves Laure Pimentel · 100問 · 2年前

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    100問 • 2年前
    Yves Laure Pimentel

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    Yves Laure Pimentel · 12問 · 2年前

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    12問 • 2年前
    Yves Laure Pimentel

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    Yves Laure Pimentel · 39問 · 2年前

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    39問 • 2年前
    Yves Laure Pimentel

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    Yves Laure Pimentel · 55問 · 2年前

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    55問 • 2年前
    Yves Laure Pimentel

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    Yves Laure Pimentel · 37問 · 2年前

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    37問 • 2年前
    Yves Laure Pimentel

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    Yves Laure Pimentel · 44問 · 2年前

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    44問 • 2年前
    Yves Laure Pimentel

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    Yves Laure Pimentel · 50問 · 2年前

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    50問 • 2年前
    Yves Laure Pimentel

    1. HISTORY

    1. HISTORY

    Yves Laure Pimentel · 69問 · 2年前

    1. HISTORY

    1. HISTORY

    69問 • 2年前
    Yves Laure Pimentel

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    Yves Laure Pimentel · 38問 · 2年前

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    38問 • 2年前
    Yves Laure Pimentel

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    Yves Laure Pimentel · 21問 · 2年前

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    21問 • 2年前
    Yves Laure Pimentel

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    Yves Laure Pimentel · 15問 · 2年前

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    15問 • 2年前
    Yves Laure Pimentel

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    Yves Laure Pimentel · 32問 · 2年前

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    32問 • 2年前
    Yves Laure Pimentel

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    Yves Laure Pimentel · 30問 · 2年前

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    30問 • 2年前
    Yves Laure Pimentel

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    Yves Laure Pimentel · 38問 · 2年前

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    38問 • 2年前
    Yves Laure Pimentel

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    Yves Laure Pimentel · 48問 · 2年前

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    48問 • 2年前
    Yves Laure Pimentel

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    Yves Laure Pimentel · 35問 · 2年前

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    35問 • 2年前
    Yves Laure Pimentel

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 18問 · 2年前

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    18問 • 2年前
    Yves Laure Pimentel

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    Yves Laure Pimentel · 44問 · 2年前

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    44問 • 2年前
    Yves Laure Pimentel

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 23問 · 2年前

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    23問 • 2年前
    Yves Laure Pimentel

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    Yves Laure Pimentel · 34問 · 2年前

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    34問 • 2年前
    Yves Laure Pimentel

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    Yves Laure Pimentel · 12問 · 2年前

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    12問 • 2年前
    Yves Laure Pimentel

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    Yves Laure Pimentel · 16問 · 2年前

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    16問 • 2年前
    Yves Laure Pimentel

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    Yves Laure Pimentel · 15問 · 2年前

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    15問 • 2年前
    Yves Laure Pimentel

    12. ANTIBODY

    12. ANTIBODY

    Yves Laure Pimentel · 79問 · 2年前

    12. ANTIBODY

    12. ANTIBODY

    79問 • 2年前
    Yves Laure Pimentel

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    Yves Laure Pimentel · 97問 · 2年前

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    97問 • 2年前
    Yves Laure Pimentel

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    Yves Laure Pimentel · 11問 · 2年前

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    11問 • 2年前
    Yves Laure Pimentel

    1. INTERLEUKINS

    1. INTERLEUKINS

    Yves Laure Pimentel · 23問 · 2年前

    1. INTERLEUKINS

    1. INTERLEUKINS

    23問 • 2年前
    Yves Laure Pimentel

    2. INTERFERONS

    2. INTERFERONS

    Yves Laure Pimentel · 28問 · 2年前

    2. INTERFERONS

    2. INTERFERONS

    28問 • 2年前
    Yves Laure Pimentel

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    Yves Laure Pimentel · 8問 · 2年前

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    8問 • 2年前
    Yves Laure Pimentel

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 19問 · 2年前

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    19問 • 2年前
    Yves Laure Pimentel

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 76問 · 2年前

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    76問 • 2年前
    Yves Laure Pimentel

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    Yves Laure Pimentel · 21問 · 2年前

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    21問 • 2年前
    Yves Laure Pimentel

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    Yves Laure Pimentel · 29問 · 2年前

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    29問 • 2年前
    Yves Laure Pimentel

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    Yves Laure Pimentel · 19問 · 2年前

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    19問 • 2年前
    Yves Laure Pimentel

    19. CYTOKINES

    19. CYTOKINES

    Yves Laure Pimentel · 22問 · 2年前

    19. CYTOKINES

    19. CYTOKINES

    22問 • 2年前
    Yves Laure Pimentel

    20. INTERLEUKINS

    20. INTERLEUKINS

    Yves Laure Pimentel · 24問 · 2年前

    20. INTERLEUKINS

    20. INTERLEUKINS

    24問 • 2年前
    Yves Laure Pimentel

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    Yves Laure Pimentel · 21問 · 2年前

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21問 • 2年前
    Yves Laure Pimentel

    1. SERO

    1. SERO

    Yves Laure Pimentel · 54問 · 2年前

    1. SERO

    1. SERO

    54問 • 2年前
    Yves Laure Pimentel

    2. PRECIPITATION

    2. PRECIPITATION

    Yves Laure Pimentel · 38問 · 2年前

    2. PRECIPITATION

    2. PRECIPITATION

    38問 • 2年前
    Yves Laure Pimentel

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    Yves Laure Pimentel · 17問 · 2年前

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    17問 • 2年前
    Yves Laure Pimentel

    4. OUCHTERLONY

    4. OUCHTERLONY

    Yves Laure Pimentel · 15問 · 2年前

    4. OUCHTERLONY

    4. OUCHTERLONY

    15問 • 2年前
    Yves Laure Pimentel

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    Yves Laure Pimentel · 9問 · 2年前

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    9問 • 2年前
    Yves Laure Pimentel

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    Yves Laure Pimentel · 11問 · 2年前

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    11問 • 2年前
    Yves Laure Pimentel

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    Yves Laure Pimentel · 29問 · 2年前

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    29問 • 2年前
    Yves Laure Pimentel

    問題一覧

  • 1

    Concentrated formalin is * 0/1 A. 10% B. 100% C. 37% D. 5%

    C. 37%

  • 2

    Staining result in the routine hematoxylin and eosin method: * 1/1 A. Nuclei pink, cytoplasm blue to blue-black B. Nuclei and cytoplasm pink C. Nuclei blue to blue-black, cytoplasm pink D. Nuclei and cytoplasm blue-black

    C. Nuclei blue to blue-black, cytoplasm pink

  • 3

    A paraffin wax substitute recommended for bones and brain specimen is * 0/1 A. Paraplast B. Bioloid C. Esterwax D. Carbowax

    A. Paraplast

  • 4

    The required fixative volume to achieve satisfactory fixation is * 1/1 A. 50-100 x the volume of the specimen B. 5-10 x the volume of the specimen C. 20 x the volume of the specimen D. 150 x the volume of the specimen

    C. 20 x the volume of the specimen

  • 5

    The fastest chemical solution in decalcifying tissues is: * 1/1 A. Trichloroacetic acid B. Formic acid C. Nitric acid D. Versene

    C. Nitric acid

  • 6

    The cryostat is an apparatus used in fresh tissue microtomy. It consists of a microtome, kept inside a cold chamber which has been maintained at a temperature of: * 1/1 A. 20ᵒC B. -20ᵒC C. 4ᵒC D. -4ᵒC

    B. -20ᵒC

  • 7

    Microtome suitable for Fatty Tissues * 1/1 A. Rotary B. Rocking C. Cold Microtome D. Sliding

    C. Cold Microtome

  • 8

    Removal of clearing agent as well as filling up tissue cavities and spaces may be accomplished using which of the following agents * 1/1 A. Amyl acetate B. methyl salicylate C. Paraffin wax D. Terpineol

    C. Paraffin wax

  • 9

    Most commonly antibody label in immunohistochemistry * 0/1 A. colloidal gold B. fluorescein isothiocyanate C. radiolabel D. horseradish peroxidase

    D. horseradish peroxidase

  • 10

    To ensure adequate fixation, slightly hypertonic solution must be used. This is about 400-450 mOsm * 0/1 A. Only the 1st statement is correct B. Only the 2nd statement is correct C. Both statements are correct D. Both statements are incorrect

    C. Both statements are correct

  • 11

    The chromogen used in partnership with HRP is * 0/1 A. Para dimethylaminobenzaldehyde B. P-dimethyl-l-naphthylamine C. Diaminobenzidine D. none of these

    C. Diaminobenzidine

  • 12

    Cellular adaptation Mechanism that involves transformation of adult cell into another adult cell type is * 0/1 A. Metaplasia B. neoplasia C. Dysplasia D. Anaplasia

    A. Metaplasia

  • 13

    Which of the following is NOT a fixing agent for EM? * 1/1 A. Paraformaldehyde B. Glutaraldehyde C. uranyl acetate D. osmium tetroxide

    C. uranyl acetate

  • 14

    Which of the following statement is TRUE regarding dehydration? * 0/1 A. The specimen is subjected to ascending concentrations of alcohol B. The specimen is subjected to several changes of alcohol with the same concentrations C. The specimen is subjected to descending concentrations of alcohol D. The specimen is subjected to both ascending and descending concentration of alcohol

    A. The specimen is subjected to ascending concentrations of alcohol

  • 15

    Secondary change in somatic death important in establishing time of death * 0/1 A. putrefaction B. algor mortis C. rigor mortis D. livor mortis

    B. algor mortis

  • 16

    Which of the following is an example of pathologic hypertrophy? * 0/1 A. Removing part of the liver /kidney B. Increase in breast and uterus size during pregnancy C. Myocardium in hypertension or aortic valve disease D. Increase in skeletal muscles following exercise

    C. Myocardium in hypertension or aortic valve disease

  • 17

    Abnormality in cell growth characterized by non-appearance of organ * 1/1 A. Aplasia B. hypoplasia C. atresia D. agenesia

    D. agenesia

  • 18

    All of the following are slow acting clearing agents hence not suited for urgent biopsies except * 1/1 A. Benzene B. clove oil C. cedarwood oil D. methyl benzoate

    A. Benzene

  • 19

    This technique entails the use of specific dyes, which differentiate substances by staining them with a color that is different from that of the stain itself: * 1/1 A. Orthochromatic staining B. Metachromatic staining C. Counterstaining D. Vital staining

    B. Metachromatic staining

  • 20

    To avoid distortion of the image, the refractive index of the mountant should be near as possible to that of the glass which is: * 1/1 A. 1. 581 B. 1.185 C.1.518 D. 1.524

    C.1.518

  • 21

    The cellular infiltrate in acute inflammation * 1/1 A. neutrophils B. plasma cells C. macrophage D. lymphocytes

    A. neutrophils

  • 22

    Fixation of tissues for EM is carried out at * 0/1 A. 22-25 degC B. 40 degC C. 4 degC D. 37 deg

    C. 4 degC

  • 23

    Which of the following are Picric acid containing fixatives? 1.Brasil’s 2. Hollande’s 3. Bouin’s 4. Regaud’s * 0/1 A. 1 and 3 B. 2 and 4 C. 1,2 and 3 D. 1,2,3 and 4

    C. 1,2 and 3

  • 24

    Clearing agent that becomes milky because of incomplete dehydration is * 1/1 A. Chloroform B. xylene C. benzene D. cedarwood oil

    B. xylene

  • 25

    Thickness of paraffin sections for routine histologic procedures: * 1/1 A.10-15 µ B. 4-6 µ C.0.5 µ D. 5-10 µ

    B. 4-6 µ

  • 26

    Process whereby the clearing agent is completely removed from the tissue and replaced by a medium that will completely fill all the tissue cavities: * 0/1 A. Embedding B. Infiltration C. Blocking D. Casting

    B. Infiltration

  • 27

    With this staining technique, the tissue is first overstained, and the excess stain is removed or decolorized from unwanted part of the tissue: * 0/1 A. Progressive staining B. Direct staining C. Regressive staining D. Indirect staining

    C. Regressive staining

  • 28

    True of Necrosis except * 1/1 A. Characterized by cell shrinkage B. There is leakage of cellular contents C. Possible inflammation in adjacent tissues D. Always a pathologic process

    A. Characterized by cell shrinkage

  • 29

    The process of decalcification is best performed: * 1/1 A. Before fixation B. After fixation C. After impregnation D. None of these

    B. After fixation

  • 30

    microscopic changes in reversible injury 1. karyorrhexis 2. fatty change 3. pyknosis 4. cellular swelling * 0/1 A. 1 and 3 B. 1 and 4 C. 2 and 4 D. 2 and 3

    C. 2 and 4

  • 31

    Autopsy technique that involves “en bloc” removal or organs * 1/1 A. R. virchow B. A. Ghon C. C. Rokitansky D. M. letulle

    B. A. Ghon

  • 32

    Black mercury deposits following fixation can be removed by using which washing reagent? * 1/1 A. 50-70% alcohol B. alcoholic iodine C. tap water D. lithium carbonate

    B. alcoholic iodine

  • 33

    Clearing agent recommended for CNS and Cytologic studies * 0/1 A. Chloroform B. Cedarwood oil C. Xylene D. Aniline oil

    B. Cedarwood oil

  • 34

    What is the most commonly used tissue fixative in routine Histopath? * 1/1 A. 95% ethanol B. 95% ethanol and ether C. 10% BNF D. Osmium tetroxide

    C. 10% BNF

  • 35

    Ciliated columnar cells lining the bronchi transforming into squamous epithelium due to excessive cigarette smoking is an example of * 1/1 A. Metaplasia B. Neoplasia C. Dysplasia D. Anaplasia E. none of these

    A. Metaplasia

  • 36

    Which of the following fixatives are classified as Mercuric Chloride Fixatives? * 1/1 A. Zenker’s, Hollande’s, B5 B. Helly’s, Brasil’s, Regauds C. Heidenhain’s Susa, B5, Zenker-formol D. orth’s, Helly’s, B5

    C. Heidenhain’s Susa, B5, Zenker-formol

  • 37

    The last container through which tissue pass through in an automatic tissue processor contains: * 0/1 A. Paraffin B. Formalin C. Xylol D. Alcohol

    A. Paraffin

  • 38

    Which of the following is added to prevent growth of molds in Mayer’s egg albumin * 1/1 A. Glycerine B. Phenol C. Thymol crystals D. sugar

    C. Thymol crystals

  • 39

    Which of the following fixatives is recommended for tumor skin biopsies * 1/1 A. Zenker’s fluid B. Heidenhain’s Susa C. Carnoy’s D. Acetone

    B. Heidenhain’s Susa

  • 40

    All of the following are metachromatic stains, EXCEPT: * 1/1 A. Thionine B. Toluidine blue C. Safranin D. Eosin

    D. Eosin

  • 41

    Liquefactive necrosis is associated with which of the following organs: * 1/1 a. Brain b. Heart c. Pancreas d. Spleen

    a. Brain

  • 42

    During dehydration, the amount in each stage should not be less than ____ times the volume of the tissue. * 1/1 a. 5 b. 10 c. 15 d. 20

    b. 10

  • 43

    All of these are the advantages of Flemming’s solution fixative for nuclear preservation, except: * 0/1 a. Less volume required for fixation b. Permanently fixes fat c. Excellent fixative for chromosomes d. Good penetrating agent

    d. Good penetrating agent

  • 44

    Resealing of the block is recommended: * 0/1 a. To prevent drying of tissues b. To prevent crumbling of tissue blocks c. To prevent deterioration of tissue within the block d. To protect the block from direct heat

    a. To prevent drying of tissues

  • 45

    All of the following statements are true about paraformaldehyde, except: * 0/1 a. Causes turbidity in formalin b. Forms from the breakdown of formalin into monomeric segments c. Can be removed by filtration d. Prevented from forming due to addition of 10-16% methanol

    b. Forms from the breakdown of formalin into monomeric segments

  • 46

    The basic FNAB technique uses what needle and syringe measurements? * 0/1 a. 25-gauge needle and 10-mL syringe b. 25-gauge needle and 5-mL syringe c. 23-gauge needle and 10-mL syringe d. 23-gauge needle and 5-ml syringe

    a. 25-gauge needle and 10-mL syringe

  • 47

    It is the process of removing mercuric deposits from fixed tissues by immersing them in alcoholic iodine solution prior to staining. * 1/1 a. Post-chromatization b. De-zenkerization c. Washing out d. Post-fixation immersion

    b. De-zenkerization

  • 48

    Mercuric chloride fixatives: 1. Zenker’s fluid 2. Heidenhain Susa solution 3. Helly’s solution 4. B5 * 0/1 a. 1, 2, 3, 4 b. 1, 2, 3 c. 1, 2, 4 d. 1, 3, 4

    a. 1, 2, 3, 4

  • 49

    In the preparation of a working solution for both Ehrlich’s and Harris hematoxylin, hematoxylin is initially dissolved in: * 0/1 a. Distilled water b. Glacial acetic acid c. Ethyl alcohol d. Deionized water

    c. Ethyl alcohol

  • 50

    Mounting solution is placed on the slide after it has passed * 1/1 a. Alcohol b. Xylol c. Hematoxylin d. Eosin

    b. Xylol

  • 51

    Brown-black granules present in the specimen due to acid formaldehyde hematin can be removed by all of the following, except: * 0/1 a. Kardasewitsch method b. Lillie’s method c. Alcoholic potassium hydroxide d. Glacial acetic acid

    d. Glacial acetic acid

  • 52

    During double embedding, a tissue specimen is initially infiltrated using _______ then embedded using ________. * 1/1 a. Celloidin, paraffin b. Paraffin, celloidin c. Celloidin, gelatin d. Paraffin, gelatin

    a. Celloidin, paraffin

  • 53

    One of these is not a special stain for fat * 1/1 a. Oil red O b. Congo red c. Sudan IV d. Scharlach R

    b. Congo red

  • 54

    It is an instrument equipped with a warm plate to manage the impregnated specimen, and a cold plate for rapid solidification of the block. * 1/1 a. Autotechnicon b. Elliot Bench-Type processor c. Vacuum embedding d. Tissue Tek

    d. Tissue Tek

  • 55

    Fixation is enhanced by: * 0/1 a. Presence of fat and mucus b. Fixing larger tissues c. Cold temperature d. Agitation

    d. Agitation

  • 56

    The following are agents for blueing, except: * 0/1 a. Lithium carbonate b. Alcohol ammonia c. Scott’s tap water d. Distilled water

    d. Distilled water

  • 57

    Widely used adhesive in IHC: * 0/1 a. Poly-L-Lysine b. APES c. XAM d. DPX

    a. Poly-L-Lysine

  • 58

    Secondary fixation can be done: 1. Before dehydration 2. Before staining 3. Depends on circumstances * 0/1 a. 1, 2, 3 b. 1 and 2 c. 1 only d. 2 only

    b. 1 and 2

  • 59

    Aplastic anemia and bone marrow disease is attributed mostly to: * 0/1 a. Xylene b. Toluene c. Chloroform d. Benzene

    d. Benzene

  • 60

    All of the following are considered resinous mounting media, except: * 1/1 a. Apathy b. Canada Balsam c. Clarite d. XAM

    a. Apathy

  • 61

    Mounting medium 1. APES 2. DPX 3. Poly-L-Lysine 4. XAM * 0/1 a. 1, 2, 3, 4 b. 1, 2, 4 c. 1 and 3 d. 2 and 4

    d. 2 and 4

  • 62

    Cytologic preparation of vulvar scrape is useful in: * 0/1 a. Patients with hysterectomy b. Hormonal evaluation c. Localization of vaginal adenosis d. Detection of herpetic lesions or carcinomas

    d. Detection of herpetic lesions or carcinomas

  • 63

    All of the following are staining method used to demonstrate CNS elements, except: * 0/1 a. Bielschowsky Technique b. Bodian’s Stain c. Cresyl fast violet d. Modified Fouchet’s technique

    d. Modified Fouchet’s technique

  • 64

    The first and most important procedure in the preparation for microscopic examination is the choice of: * 1/1 a. Fixative b. Dehydrating agent c. Clearing agent d. Staining technique

    a. Fixative

  • 65

    The fluorescent stain for amyloid is: * 0/1 a. Congo red b. Argentaffin c. Thioflavin T d. Toluidine blue

    c. Thioflavin T

  • 66

    To demonstrate antibodies and enzymes in tissues, the following procedure is used: * 1/1 a. Special staining technique b. Electron microscopy c. Frozen section examination d. Routine H&E

    c. Frozen section examination

  • 67

    Xylene turns milky as soon as tissue is placed in it. What could be the possible cause? * 1/1 a. Incomplete dehydration b. Incomplete fixation c. Prolonged dehydration d. Prolonged fixation

    a. Incomplete dehydration

  • 68

    A special method of smear preparation whereby the surface of a freshly cut piece of tissue is brought into contact and pressed onto the surface of a clean glass slide, allowing cells to be transferred directly to the slide for examination: * 0/1 a. Impression smear b. Pull apart c. Streaking d. Crushing

    a. Impression smear

  • 69

    All of the following tests are used for the detection of the completion of decalcification, except: * 1/1 a. Physical or mechanical b. Absorption test c. Chemical test d. X-ray or radiologic test

    b. Absorption test

  • 70

    Slices of organs taken at autopsy (except lung) should not be * 1/1 a. More than 10 mm thick b. Less than 5 mm thick c. More than 5 mm thick d. Less than 10 mm thick

    c. More than 5 mm thick

  • 71

    In autopsy, microbiological culture to demonstrate infection of the central nervous system can use which of the following specimen: * 0/1 a. Fresh serum b. Fresh cerebrospinal fluid c. Whole blood d. Fresh brain tissue

    d. Fresh brain tissue

  • 72

    This fixative is used to demonstrate early degenerative processes and tissue necrosis; can be used for fixation of Rickettsia and other microorganisms * 0/1 a. Regaud’s Fluid b. Moller’s Fluid c. Chromic Acid d. Orth’s Fluid

    d. Orth’s Fluid

  • 73

    Non-chemical technique/s useful in preserving neurochemical substances in brain, such as acetylcholine. * 0/1 a. Microwave Technique b. Vacuum Technique c. Heating Technique d. All of the above

    d. All of the above

  • 74

    What percentage of formalin is distributed commercially? * 0/1 a. 10% b. 40% c. 100% d. 4%

    b. 40%

  • 75

    Airholes found in tissue during trimming is: * 1/1 a. Drying out of tissue before actual fixation b. Incomplete fixation c. Incomplete impregnation d. Prolonged clearing

    c. Incomplete impregnation

  • 76

    The most popular and commonly used embedding medium is * 1/1 a. Carbowax b. Paraplast c. Paraffin d. Celloidin

    c. Paraffin

  • 77

    77. Picric acid fixatives, except: 1. Helly’s 2. Heidehain Susa solution 3. Orth’s fluid 4. B5 * 0/1 a. 1, 2, 3, 4 b. 1, 2, 3 c. 4 only d. None

    a. 1, 2, 3, 4

  • 78

    What substance is used to test water content in alcohol used for dehydration? * 1/1 a. Anhydrous copper sulfate b. Anyhydrous copper oxide c. Anhydrous copper silicide d. Anhydrous copper sulfide

    a. Anhydrous copper sulfate

  • 79

    The turnover of results for frozen sections should be within: * 1/1 a. 24 hours b. 5-15 minutes c. 1 week d. 3 days

    b. 5-15 minutes

  • 80

    Use of EDTA as a decalcifying agent inactivates alkaline phosphatase activity. What reagent is added to restore enzymatic activity? * 1/1 a. Magnesium chloride b. Acid lithium carbonate c. Copper sulfate d. Lead bromide

    a. Magnesium chloride

  • 81

    As to service capability, a primary laboratory caters: I. Routine Clinical Chemistry II. Routine Hematology and Urinalysis III. Bleeding time IV. Quantitative platelet determination * 0/1 A. I, II, III B. I, II, IV C. I, III, IV D. All of these

    C. I, III, IV

  • 82

    Validity of COA of a screening Drug Test Laboratory: * 1/1 A. 6 months B. 1 year C. 2 year D. Indefinite

    B. 1 year

  • 83

    The current PRC Chairperson is: * 1/1 A. Charito Zamora B. Jose Cueto C. Erwin Enad D. Luella Vertucio

    A. Charito Zamora

  • 84

    Fist clinical laboratory in the Philippines: * 1/1 A. San Lazaro Hospital B. Manila Public Health Laboratory C. Research Institute for Tropical Medicine D. National Reference Laboratory

    B. Manila Public Health Laboratory

  • 85

    A sample of persons from a population is enrolled and their exposures and health outcomes are measured simultaneously. * 1/1 A. Cross-sectional study B. Cohort study C. Case control studies D. Causation Study

    A. Cross-sectional study

  • 86

    Refers to a list of minimum legally core parameters for drinking water analysis such as total dissolved solids, thermotolerant coliform and chemicals: * 0/1 A. Water Analysis Parameters B. Control parameters C. Bacteriological Parameters D. Mandatory Parameters

    D. Mandatory Parameters

  • 87

    National Reference Laboratory for Environmental and Occupational Health; Toxicology and Micronutrient Assay: * 0/1 A. RITM B. San Lazaro Hospital C. East Avenue Medical Center D. Lung Center of the Philippines

    C. East Avenue Medical Center

  • 88

    A deceased individual and includes a stillborn infant or fetus: * 1/1 A. Testator B. Donor C. Decedent D. Part

    C. Decedent

  • 89

    RESPECT the decisions (self-determination) of adult who have decision-making capacity. Moral rules or obligations: ▪ Tell the truth ▪ Respect the privacy ▪ Protect confidential information ▪ Obtain consent for interventions with patients * 1/1 A. Autonomy B. Beneficence C. Non-maleficence D. Justice

    A. Autonomy

  • 90

    What is the most important role of the manager in charge? * 0/1 A. Independent decision making B. Communication C. Informal discussions D. None of the above

    B. Communication

  • 91

    ISO Standard and certification formulated for clinical laboratories: * 0/1 A. ISO 15179 B. ISO 15197 C. ISO 15189 D. ISO 15198

    D. ISO 15198

  • 92

    Consists of educational arrangements such as curricular qualifications and teaching-learning requirements that leads to diplomas and qualifications: * 0/1 A. Formal learning B. Non-formal learning C. Informal learning D. Professional work experiences

    A. Formal learning

  • 93

    All of the following are Quality Management errors during the post examination phase, except: * 1/1 A. Failure to call critical values B. Inability to identify interfering substance C. Misinterpretation of QC data D. Poor handwriting

    C. Misinterpretation of QC data

  • 94

    When fire is first discovered: * 1/1 A. Alarm - Rescue - Contain – Extinguish /Evacuate B. Rescue - Alarm - Contain – Extinguish/Evacuate C. Rescue - Alarm – Contact personnel – Extinguish/Evacuate D. Rescue - Alarm – Extinguish/Evacuate - Contact personnel

    B. Rescue - Alarm - Contain – Extinguish/Evacuate

  • 95

    An agency attached to DOH that is primarily tasked to ensure the implementation of the country’s response to the HIV and AIDS situation: * 1/1 A. Philippine Red Cross B. Philippine National AIDS Council (PNAC) C. Philippine Movement AIDS Council D. None of these

    B. Philippine National AIDS Council (PNAC)

  • 96

    Any members of the Board may be removed by the President of the Philippines for: I. Neglect of Duty II. Incompetency III. Non-compliance IV. Malpractice V. Dishonorable conduct VI. Tardiness * 1/1 A. I, II, III, IV B. I, II, III, V C. I, III, IV, V D. I, II, IV, V

    D. I, II, IV, V

  • 97

    When washing hands, rinse hands in a _______ position to prevent recontamination of hands and wrists: * 1/1 A. Upward B. Downward C. Facing the faucet D. None of these

    B. Downward

  • 98

    Every applicant who has satisfactorily passed the required examination for medical technologist shall be issued a certificate of registration (COR) as such: Provided, that no such certificate shall be issued to any successful applicant who has not attained the age of _____. * 1/1 A. 20 y/o B. 21 y/o C. 22 y/o D. 23 y/o

    B. 21 y/o

  • 99

    Organ Donation Act of 1991: * 1/1 A. RA 1517 B. RA 4688 C. RA 7170 D. RA 9165

    C. RA 7170

  • 100

    R.A 11223: * 0/1 A. Universal Health Care Act B. Human Trafficking Act of 1995 C. Science and Technology Act D. Universal Water Care Act

    D. Universal Water Care Act